Ophthalmology News

Ophthal

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Lott MN et al. – For eyes with CNV, BCVA improved significantly at follow–up month 1, but was not different from baseline thereafter; CST remained unchanged throughout follow–up. For eyes with CME, neither BCVA nor CST changed significantly over the course of follow–up. Bevacizumab appears to stabilize BCVA and CST for eyes with inflammatory CNV or CME.

Related Articles

Analysis of Inflammatory Cytokines in the Tears of Dry Eye Patients
Cornea, 10/14/09    Relevance Score: 81%

Update on thyroid eye disease and management
Clinical Ophthalmology, 10/19/09    Relevance Score: 80%

Cyclosporine helps revent progression of dry eye
Ophthalmology Times Europe, 10/08/09    Relevance Score: 80%

Pathogenesis of inflammatory bowel disease (IBD)
The Internet Journal of Gastroenterology, 11/13/09    Relevance Score: 70%

Genetics of inflammatory bowel disease: implications for disease pathogenesis and natural history
Expert Review of Gastroenterology & Hepatology, 10/13/09    Relevance Score: 70%

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address